Literature DB >> 8867246

Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations.

Tony Mosconi1, Lawrence Kruger.   

Abstract

Polyethylene cuffs of varying inner diameters were applied to the rat sciatic or sural nerve with the aim of inducing a standardized nerve injury, as assessed by morphometric analyses of fiber-size spectrum alterations, associated with behavioral manifestations of neuropathic pain. The temporal sequence of axonal degeneration and regeneration was examined in parallel with behavioral analyses of pain initiation and recovery over a 6-week postoperative (PO) period. Cuffs of 0.028-0.030" inner diameter loosely enclosed sciatic nerves of young rats and elicited relatively uniform axonal degeneration and 'pain'. Large myelinated axons underwent an early and sustained numerical depletion. Both the thinly myelinated and unmyelinated axon populations were initially diminished, but later rose to levels significantly greater than control values, likely the result of: (1) demyelination, (2) early stages of remyelination, (3) regenerative sprouting, and/or (4) collateral sprouting of undamaged unmyelinated axons. Pathological alterations of the injured nerve included edematous swelling, hypertrophy of the perineurial sheath, infiltration of fibroblasts and collagen into the intraneurial compartment, increasing interaxonal space and decreasing order and density of axonal packing. Animals displayed maximal pain-related behaviors, including gait and postural asymmetries and hypersensitivity to mechanical compression and cold, during the 2nd week PO and had largely recovered by approximately 4 weeks PO. Consistent behavioral manifestations of pain were achieved over a wide range of fiber spectrum alteration; however, with the largest cuffs or 'bracelets' used in this study, a substantial axonal fiber spectrum change was produced without inducing pain-related behavior, suggesting that decrement in the number of myelinated axons was not always sufficient to elicit pain. Similar morphometric and pathological results were achieved with sural neuropathy after 0.010" ID cuffs and 14 days PO survival. Considering the lack of correlation between axonal alterations and pain, modification in the local intraneurial microenvironment at the site of injury may be a key component of peripheral pain mechanisms; these include changes in the biochemical milieu, increased intraneurial pressure, and altered nociceptor sensitivity or impulse propagation in the relatively intact unmyelinated axon population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867246     DOI: 10.1016/0304-3959(95)00077-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  53 in total

1.  The density of nociceptive SP- and CGRP-immunopositive nerve fibers in the dura mater lumbalis of rats is enhanced after laminectomy, even after application of autologous fat grafts.

Authors:  Guido Saxler; Jochen Brankamp; Marius von Knoch; Franz Löer; Gero Hilken; Ulrike Hanesch
Journal:  Eur Spine J       Date:  2008-08-15       Impact factor: 3.134

2.  An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain.

Authors:  Yong Fang Zhu; Katja Linher-Melville; Mohammad Javad Niazmand; Manu Sharma; Ayesha Shahid; Kan Lun Zhu; Natalka Parzei; Jesse Sidhu; Christeene Haj; Raphael Mechoulam; Gurmit Singh
Journal:  Br J Pharmacol       Date:  2020-03-08       Impact factor: 8.739

3.  Microglia disrupt mesolimbic reward circuitry in chronic pain.

Authors:  Anna M W Taylor; Annie Castonguay; Alison J Taylor; Niall P Murphy; Atefeh Ghogha; Christopher Cook; Lihua Xue; Mary C Olmstead; Yves De Koninck; Christopher J Evans; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

4.  Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats.

Authors:  M E Fundytus; K Yashpal; J G Chabot; M G Osborne; C D Lefebvre; A Dray; J L Henry; T J Coderre
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.

Authors:  Herbert H Seltzman; Craig Shiner; Erin E Hirt; Anne F Gilliam; Brian F Thomas; Rangan Maitra; Rod Snyder; Sherry L Black; Purvi R Patel; Yatendra Mulpuri; Igor Spigelman
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

Review 6.  The emergence of animal models of chronic pain and logistical and methodological issues concerning their use.

Authors:  Terence J Coderre; André Laferrière
Journal:  J Neural Transm (Vienna)       Date:  2019-11-18       Impact factor: 3.575

7.  Topography of microglial activation in sensory- and affect-related brain regions in chronic pain.

Authors:  Anna M W Taylor; Sadaf Mehrabani; Steve Liu; Alison J Taylor; Catherine M Cahill
Journal:  J Neurosci Res       Date:  2016-08-30       Impact factor: 4.164

8.  Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.

Authors:  Yohann Bohren; Dzenan Karavelic; Luc-Henri Tessier; Ipek Yalcin; Claire Gavériaux-Ruff; Brigitte L Kieffer; Marie-José Freund-Mercier; Michel Barrot
Journal:  Eur J Pain       Date:  2009-12-28       Impact factor: 3.931

9.  Correlation between ventral striatal catecholamine content and nociceptive thresholds in neuropathic mice.

Authors:  Anna M W Taylor; Niall P Murphy; Christopher J Evans; Catherine M Cahill
Journal:  J Pain       Date:  2014-06-02       Impact factor: 5.820

10.  Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy.

Authors:  Devang Kashyap Thakor; Audrey Lin; Yoshizo Matsuka; Edward M Meyer; Supanigar Ruangsri; Ichiro Nishimura; Igor Spigelman
Journal:  Mol Pain       Date:  2009-03-25       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.